Door-to-GDMT Time: The Effect of De Novo Diagnosis of Heart Failure on Guideline-directed Medical Therapy Optimisation During the Rapid-up Titration Programme and on Prognosis
by Prateek Chopra | May 27, 2026 | Cardiology Conferences | ESC-HF 2026 Early initiation of guideline-directed medical therapy (GDMT) has shown significant prognostic benefits in heart failure (HF). Despite strong evidence for life-saving drug therapy, previous real-world registries of chronic HF patients have consistently revealed low prescription rates and underdosing of GDMT. Accordingly, the 2023 ESC HF guidelines recommend rapid […]


